UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
10.14
-1.00 (-8.98%)
At close: May 13, 2025, 4:00 PM
10.36
+0.22 (2.17%)
Pre-market: May 14, 2025, 7:00 AM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $467.53 million as of May 14, 2025. Its market cap has decreased by -0.86% in one year.
Market Cap
467.53M
Enterprise Value
393.49M
1-Year Change
-0.86%
Ranking
Category
Stock Price
$10.14
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $467.53M, an increase of 157.03%. That is a compound annual growth rate of 12.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 513.60M | 14.29% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |